Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.30
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsUPMC Health Plan Nexviazyme Prior Auth | OpenPayer
    Ask Trek AI about this page
    CurrentUPMC Health PlanPolicy RX.PA.643

    Avalglucosidase alfa-ngpt (Nexviazyme) – Medicaid

    Customize your policy alerts

    Sign up for UPMC Health Plan Policy RX.PA.643 alerts

    Get alerted when Policy RX.PA.643 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy appears to govern Medicaid prior authorization for avalglucosidase alfa-ngpt (Nexviazyme). The available source text contains only document-viewer metadata and does not provide clinical coverage criteria or authorization requirements.

    Policy Summary
    PayerUPMC Health Plan
    PolicyAvalglucosidase alfa-ngpt (Nexviazyme) – Medicaid
    Policy CodePolicy RX.PA.643
    Change TypeNo material change
    Effective DateNot provided
    Next Review DateNot provided
    Key ActionNo provider authorization requirements are stated in the available source text.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    Policy Summary
    PayerUPMC Health Plan
    PolicyAvalglucosidase alfa-ngpt (Nexviazyme) – Medicaid
    Policy CodePolicy RX.PA.643
    Change TypeNo material change
    Effective DateNot provided
    Next Review DateNot provided
    Key ActionNo provider authorization requirements are stated in the available source text.
    SourceLink

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.